Rural Pharmacy and Prescription Drugs – News
News stories from the past 60 days.
DEA, HHS: Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Federal Register
Nov 19, 2024 - Notice from the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) issuing a temporary rule to extend certain exceptions to existing DEA regulations implemented in March 2020 because of the COVID-19 Public Health Emergency (COVID-19 PHE). The full set of telemedicine flexibilities regarding the prescription of controlled medications that were in place during the COVID-19 PHE as outlined in the Second Temporary Rule will remain in place through December 31, 2025. This rule is effective January 1, 2025, through December 31, 2025.
Source: Federal Register
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Oct 28, 2024 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on a new information collection request titled "Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) Information Collection Request." CMS will collect information from manufacturers of Medicare Part D drugs selected for negotiation under the Inflation Reduction Act for the initial price applicability years 2026 and 2027 and the dispensing entities that dispense the selected drugs to maximum fair price (MPF)-eligible individuals. CMS will also use a Medicare Transaction Facilitator (MTF) to facilitate the effectuation of MPFs. Comments are due by December 27, 2024.
Source: Federal Register
CMS: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program
Federal Register
Sep 26, 2024 - Notice from the Centers for Medicare & Medicaid Services (CMS) implementing policies in the Medicaid Drug Rebate Program (MDRP) related to the new legislative requirements in the Medicaid Services Investment and Accountability Act of 2019 (MSIAA). Among other things, this rule finalizes several other proposed program integrity and program administration provisions or modifications. This rule also rescinds revisions made by the December 31, 2020, final rule consistent with a May 2022 court order. These regulations are effective November 19, 2024.
Source: Federal Register
Last Updated: 11/18/2024